Marketing built for regenerative medicine.

Regenerative medicine has the hardest acquisition problem of any practice type we work with, and it is hard for a specific reason: the two things that would normally sell a treatment are the two things you are not allowed to say. Outcomes and cures are off the table. So is any implication that a therapy carries approval it does not have. What remains is a high-ticket, long-consideration purchase that has to be sold without the vocabulary the rest of medicine takes for granted.

Plenty of clinics resolve that by ignoring it. They run ads promising relief, publish testimonials that function as outcome claims, and describe treatments in terms that would not survive a careful reading. It works until it does not, and the failure mode is not a rejected ad. It is a permanently disabled account, or a letter from a regulator who has been paying attention to this category for years.

The clinics that do this properly reach the same patients on a different route. They teach.

Education is the acquisition strategy

A patient considering a regenerative treatment plan is doing something unusual. They are researching a therapy most of their friends have not heard of, that their orthopaedist may have discouraged, that insurance will not cover, and that costs as much as a used car. They read for weeks. They watch hours of video. They look for someone who will explain the thing honestly, including who it does not work for.

That is a low bar to clear and almost nobody clears it, because honest explanation makes a worse advertisement than a promise does. Which is exactly why it works. The practice that publishes the clear account of what the treatment is, what the evidence does and does not support, and which patients are poor candidates ends up as the source the patient trusts, and trust is what gets booked at this price point.

It is a volume problem as much as a quality one. One well-written page does not do it. It takes sustained long-form, video, and search content covering the condition and the alternatives, published consistently enough that a patient researching across six weeks keeps arriving back at the same practice.

Seminars and webinars carry more weight than a page

Nothing on a website does what an hour of a clinician explaining the treatment does. It demonstrates that a person with actual judgement stands behind the program, it lets patients hear the questions other patients ask, and it answers the objection almost every one of them arrives with, which is whether this is legitimate.

The constraint is never the presentation. It is attendance. Registrations are easy to collect from people in pain late at night and hard to convert into a room two weeks later, so the sequences around the event decide the outcome: confirmation, reminders across more than one channel, a reason to turn up, and a route back in for the people who miss it. Practices that fix the attendance problem usually find the seminar format they had abandoned works perfectly well.

The cycle is long and the follow-up has to outlast it

A patient weighing a five-figure treatment plan is comparing it against surgery, against another year of conservative care, and against doing nothing, and there is usually a spouse in the conversation. Months pass. Campaigns judged on a thirty day return look like failures and get cancelled roughly a month before the inquiries they generated would have started converting.

The corollary is that nurture has to stay live far longer than most practices run it. An inquiry from February that was not ready is not a dead lead, it is a patient whose pain has not yet made the decision for them. Sequences that keep teaching for months cost nothing in additional spend and recover cases that would otherwise go to whichever clinic happened to be in front of the patient in June.

It also changes the consult. A patient who has read your material for six weeks and attended a webinar arrives to discuss candidacy and scheduling, not to hear the pitch from the start. Handling the cost conversation in advance rather than at the end of the appointment matters for the same reason.

We run the whole path as one system: claim-safe campaign creative, education content at the volume the research cycle demands, seminar and webinar funnels built around attendance, nurture that stays live for months, consult preparation, and reporting tied to consults attended and treatment plans started.

Ad spend stays separate and goes directly to the platforms. Engagements typically run $1,000 to $5,000 a month depending on service lines and locations.